Morgan Stanley Starts Life360 (LIF) at Overweight
Morgan Stanley analyst James Bales initiates coverage on Life360 (NASDAQ: LIF) with a Overweight rating and a price target of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
